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Sociodemographic factors associated with
IgG and IgM seroprevalence for human
cytomegalovirus infection in adult
populations of Pakistan: a seroprevalence
survey
Saira Ibrahim1, Anwar A. Siddiqui1, Amna R. Siddiqui2, Waquaruddin Ahmed3, Paul A. H. Moss4 and El-Nasir M. A. Lalani5*
Abstract
Background: The seroprevalence of human cytomegalovirus (HCMV) infection ranges from 30 to 90 % in developed
countries. Reliable estimates of HCMV seroprevalence are not available for Pakistan. This study determined the
seroprevalence and sociodemographic factors associated with HCMV infection in adult populations of Karachi, Pakistan.
Methods: A seroprevalence survey was conducted on 1000 adults, including residents of two semi-urban
communities, and visitors to a government and a private hospital. Questionnaire-based interviews were conducted.
Sera were analysed for HCMV-specific IgG and IgM. Chi-square or Fisher’s exact test was used for comparing
sociodemographic variables against seropositivity of HCMV-IgG or IgM. Multiple logistic regression modeling was
performed for IgG seroprevalence and adjusted odds ratios were computed.
Results: The seroprevalence of HCMV-IgG and IgM was 93.2 and 4.3 % respectively. 95.3 % of individuals who were
IgM seropositive were also seropositive for IgG. Around 6 % (15/250) of women of childbearing age remained
uninfected and were therefore susceptible to primary infection. HCMV-IgG seroprevalence was associated with being
female (p = 0.001), increasing age (p = 0.002) and crowding index (p = 0.003) and also with lower levels of both
education (p < 0.001) and income (p = 0.008). Seroprevalence also differed significantly by marital status (p = 0.008)
and sampling location (p < 0.001). A logistic regression model for HCMV-IgG seroprevalence showed associations with
being female (OR = 1.89; 95 % CI: 1.10–3.25), increasing age (OR = 3.95; 95 % CI: 1.79–8.71) and decreasing income
(OR = 0.72; 95 % CI: 0.54–0.96). A strong association was observed between increased seroprevalence of HCMV-IgM
and decreasing household size (p = 0.008).
Conclusions: Seroprevalence of HCMV is very high in Pakistan, although 6 % of women of childbearing age remain at
risk of primary infection. The IgM seropositivity observed in some individuals living in small household size
(1–3 individuals) with persistent HCMV infection could have resulted from a recurrent HCMV infection. Future
longitudinal research in pregnant women and neonates is required to study the trends in HCMV seroprevalence over
time in Pakistan for the development of a potential HCMV prevention and vaccination programme.
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Background
Human cytomegalovirus (HCMV) is a member of the
Herpesviridae family, and the virus may be shed intermit-
tently in bodily fluids (saliva, urine, semen, blood and
breast milk) [1]. As such, its transmission occurs both
horizontally and vertically through close contact and
directly from mother to embryo, fetus, or baby [2]. Upon
primary infection, which is usually asymptomatic [3],
HCMV establishes a state of lifelong latency, during which
infectious virus is difficult to isolate [4]. Active HCMV
infection can result from primary infection in a previously
seronegative individual or reactivation in a seropositive
individual [5] in response to immunosuppression and
inflammation [6]. Viral reactivation is associated with
significant morbidity and mortality in immunocomprom-
ised individuals, such as patients with HIV infection or
those undergoing solid organ or bone marrow transplant-
ation, and up to 15 % of babies who acquire congenital
infection, manifest signs of cytomegalic inclusion disease
(CID) at birth [1].
Seroprevalence of HCMV varies from 30 to 90 % in
most developed countries [1] and the seroprevalence is
dependent on sociodemographic factors [7]. Adult popula-
tions in Africa [8], Asia [9–11] and South America [12, 13]
have higher HCMV seroprevalence than European [14–16]
and North American populations [7]. In addition, sero-
prevalence is reported with increasing age [7] and an
inverse correlation with socioeconomic status [17, 18].
Most HCMV seroepidemiological studies have previ-
ously focused on children and women of childbearing age,
as they constitute groups at highest risk of developing
HCMV infection [19, 20]. Studies determining seropreva-
lence of HCMV-IgG antibodies in the general population
are predominantly limited to developed countries that
have assessed the impact of sociodemographic factors on
HCMV-IgG seropositivity [7, 18]. Similar research in de-
veloping countries are lacking in terms of sample size and
in depth analysis of sociodemographic data [9, 12]. More-
over, the sociodemographic characteristics of HCMV-IgM
seroprevalence have not been widely explored both in
developed and developing countries.
At the current time, there is minimal information
regarding the epidemiological determinants of HCMV
infection in Pakistan [21]. We undertook a study to
determine the seroprevalence of HCMV-specific IgG
and IgM antibodies and also to identify the sociodemo-
graphic factors associated with HCMV-IgG and HCMV-
IgM seropositivity in adult populations of Karachi,
Pakistan.
Methods
Study design and locations
We conducted a seroprevalence survey during the period
from July 2010 to June 2012 in adult populations of
Karachi, Pakistan. Study locations comprised of two major
hospitals and two medical camps held in two semi-urban
communities. The hospital location comprised of gastro-
enterology sections of two major tertiary care government
and private hospitals, namely, Jinnah Postgraduate Medical
Centre (JPMC) and Aga Khan University Hospital (AKUH)
respectively. The Department of Gastroenterology and
Hepatology unit at JPMC serves as a screening centre for
patients from across Pakistan suspected of being infected
with hepatitis B or C. The section of gastroenterology at
AKUH provides high quality standard care for liver and
pancreato-biliary diseases and also serves as a referral
centre for interventional procedures to treat gastrointes-
tinal ailments. Visitors to JPMC are predominantly from a
lower socioeconomic class whilst most patients attending
AKUH are of middle to high socioeconomic status.
Karachi is a metropolitan city with six districts, divided
into 18 towns [22]. It has a multi-ethnic and multi-lingual
population, majority being Sindhi and Urdu speaking.
Two semi-urban communities, namely, Jam Goth and
Radho Jokhio Goth were selected from Malir town and
Gadap town respectively, located in Malir district, Karachi.
Area wise, Gadap town is larger than Malir town, the
latter being more densely populated. Gadap town is
amongst the least developed areas of Karachi whilst Malir
town is relatively more developed. Both towns are inhab-
ited by ethnically diverse communities.
Study population and sampling
All consenting males and females (N = 1000) aged 18 years
or older at the time of enrolment were included in this
study. The study population comprised of patients visiting
the gastroenterology sections of JPMC and AKUH, and
people residing in two semi-urban communities; and for
analysis purpose identified as community A (Malir town)
and community B (Gadap town). The sample size estimate
was based on the assumption that approximately 80 % of
the population would be seropositive for HCMV [23]. An
alpha level of 0.05, margin of error of 3.5 %, and design
effect of 2 was used for sample size calculation.
Participants from the two towns were approached after
consultation, discussion, engagement and agreement of
community leaders with whom the aims of our study
were explained. In all sampling locations, a convenient
sampling technique was employed to select the study
participants. The study objectives were explained to the
study participants in the simplest possible manner to
satisfy the understanding of the respondents. A blood
sample was collected and a questionnaire-based inter-
view was conducted with all consenting participants.
Questionnaire and data collection
The questionnaire-based interviews were designed to
obtain personal and sociodemographic information of
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the participants. The contents of the questionnaire were
in compliance with previous studies conducted to deter-
mine associated factors of HCMV infection [7, 17]. The
questionnaire was developed in English and translated
into Urdu (the national language of Pakistan). The
English and Urdu versions were pre-tested by conduct-
ing in-person interviews of the staff at the AKUH and
residents of community A respectively and both versions
were modified accordingly.
The sociodemographic characteristics of the partici-
pants were assessed by a set of variables, namely, age
(years), gender, marital status (married/unmarried/di-
vorced/widowed/separated), ethnicity defined by mother
tongue (Sindhi/Baloch/Punjabi/Pakhtoon/Urdu speak-
ing/Other), education level (years of school attended),
house construction material (straw or wood or mud/mix
of mud and concrete bricks/concrete bricks only),
monthly household income was asked in local currency
of Rupees, and for analysis purpose was converted as
equivalent to U.S. dollars (USD), number of rooms in
the house and household (HH) size that was defined as
total number of people living together in the same
house; the last two variables were used as indicators of
crowding to create a new variable ‘crowding index’ (total
number of residents per household divided by the total
number of rooms in house). Continuous variables for
age, income, household size and crowding index when
categorised were done using quartiles. Some variables
were categorised into two categories if sparse data were
available, for example, few participants were either
divorced, widowed or separated, then the marital status
was grouped into two categories of married and
unmarried.
Laboratory analysis
Samples of up to five ml of blood were collected in
serum separation tubes (BD Biosciences, San Jose, CA,
USA). Serum was separated and analysed for the
presence of HCMV-IgG or IgM in duplicate using com-
mercial enzyme immunoassay kits (BioCheck Inc, Foster
City, CA, USA). Absorbance was recorded at 450 nm
within 15 min on a Chameleon Microplate Reader
(Hidex, Turku, Finland). Positive and negative results of
the assays were determined according to the manufac-
turer’s specifications.
Statistical analysis
Data entry and statistical analysis were performed using
SPSS version 19.0 (IBM Corporation, Chicago, IL, USA).
Continuous variables were checked for normal distribu-
tion and log transformation was attempted to improve
the distribution and when necessary were categorised
according to median and quartiles. The outcome vari-
ables were the positive or negative sero-status of
HCMV-IgG and IgM. Cross tabulations were performed
against the sociodemographic variables. Chi-square or
Fisher’s exact test was used as a statistical test of signifi-
cance for comparing sociodemographic variables against
seropositivity of HCMV-IgG or IgM. A p value of < 0.05
from two-tailed tests was considered significant in all
tests. Odds ratios (OR) and 95 % confidence intervals
(CI) were calculated for the relationships between
sociodemographic variables and seropositive status for
HCMV-IgG or IgM. Multiple logistic regression model-
ing was performed for IgG seroprevalence and adjusted
ORs were computed.
Results
Of the 1000 participants, 63.4 % were enrolled at the gov-
ernment hospital and nearly 14.9 % at the private hospital
whilst 3.6 % in community A and 18.1 % in community B
were recruited. The study group comprised of 46.3 % males
and 53.7 % females with a mean age of 36 years (standard
deviation [SD] = 12.6). The mean age of males and females
was 35.3 years (SD = 13) and 36.6 years (SD = 12.3)
respectively. There were more than six ethnic groups;
Sindhi (30.1 %), Baloch (9.9 %), Punjabi (11.9 %), Pakhtoon
(14.1 %), Urdu speaking (19.9 %), and ‘Other’ (14.1 %).
Overall, 36.8 % of the participants were not literate whilst
13.8, 23.7 and 25.7 % reported 1-6, 7-10 and > 10 years of
education respectively. The majority of participants
(66.6 %) lived in concrete houses compared with 33.4 %
inhabiting houses made of straw/wood/mud or mix of
mud and concrete. Only 9.1 % of individuals lived in
houses with ≤ 3 persons per household. The distribution
of household crowding index of participants was ≤ 2
(28.9 %), > 2-3 (20.9 %), > 3-5 (27.5 %), and > 5 (22.7 %).
Monthly income varied from ≤USD 70 in 30.6 %, USD
71–100 in 21.1 %, USD 101–200 in 25.3 %, and >USD
200 in 23 % (Table 1).
The seroprevalence of HCMV-IgG was 93.2 % (95 %
confidence interval [CI]: 91.5–94.6). The seroprevalence
of IgG differed by sampling location, as there were
83.9 % (125/149) from private hospital visitors, 95 %
(602/634) from government hospital visitors, 86.1 % (31/
36) from community A residents, and 96.1 % (174/181)
from community B residents. Using private hospital as
reference, government hospital and community B partic-
ipants had greater odds of being IgG positive. Similarly,
females and married persons had greater odds of being
IgG positive than males and unmarried persons respect-
ively. Older age groups had higher prevalence of IgG
and younger age groups displayed more IgG seronegativ-
ity (Table 1). Over 80 % of males and females were
already infected with HCMV by the age of ≤ 25 years.
However, seroprevalence varied by a 10 % difference
between males (84.6 %) and females (94.4 %) in this age
group. Seroprevalence in females remained consistently
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Table 1 Seroprevalence of anti-HCMV IgG antibodies in relation to sociodemographic characteristics of the study population
Characteristic Total IgG+ IgG− OR (95 % CI) p*
N = 1000 n = 932 n = 68
% (%) (%)
Sampling location <0.001
Private hospital 14.9 125 (13.4) 24 (35.3) 1.0
Government hospital 63.4 602 (64.6) 32 (47.1) 3.61 (1.98–6.57)
Community A 3.6 31 (3.3) 5 (7.4) 0.20 (0.04–0.92)
Community B 18.1 174 (18.7) 7 (10.3) 4.77 (1.88–12.60)
Gender 0.001
Female 53.7 514 (55.2) 23 (33.8) 2.41 (1.39–4.18)
Male 46.3 418 (44.8) 45 (66.2) 1.0
Age (years)a 0.002
≤ 25 26.1 232 (24.9) 28 (41.2) 1.0
26–34 24.3 222 (23.8) 20 (29.4) 1.34 (0.71–2.55)
35–45 27.7 268 (28.8) 8 (11.8) 4.04 (1.72–9.84)
> 45 22.0 207 (22.2) 12 (17.6) 2.08 (0.99–4.46)
Marital status 0.008
Married 76.5 722 (77.5) 43 (63.2) 2.0 (1.16–3.45)
Unmarried 23.5 210 (22.5) 25 (36.8) 1.0
Ethnicity 0.34
Sindhi 30.1 281 (30.2) 20 (29.4) 0.49 (0.14–1.56)
Baloch 9.9 91 (9.8) 8 (11.8) 0.40 (0.10–1.51)
Punjabi 11.9 115 (12.3) 4 (5.9) 1.0
Pakhtoon 14.1 131 (14.1) 10 (14.7) 0.46 (0.12–1.64)
Urdu speaking 19.9 180 (19.3) 19 (27.9) 0.33 (0.09–1.06)
Other 14.1 134 (14.4) 7 (10.3) 0.67 (0.16–2.61)
Education level (years of schooling) <0.001
0 36.8 356 (38.2) 12 (17.6) 4.52 (2.20–9.45)
1–6 13.8 133 (14.3) 5 (7.4) 4.06 (1.47–12.11)
7–10 23.7 220 (23.6) 17 (25.0) 1.97 (1.03–3.80)
> 10 25.7 223 (23.9) 34 (50.0) 1.0
Household size (no. of persons)a 0.98
1–3 9.1 83 (9.0) 7 (10.3) 1.0
4–6 31.2 289 (31.3) 20 (29.4) 1.22 (0.45–3.18)
7–10 36.9 340 (36.9) 25 (36.8) 1.04 (0.51–2.07)
> 10 22.8 210 (22.8) 16 (23.5) 1.11 (0.40–2.99)
Household income (USD) 0.008
≤ 70 30.6 291 (31.2) 15 (22.1) 2.58 (1.28–5.23)
71–100 21.1 198 (21.2) 13 (19.1) 2.03 (0.97–4.28)
101–200 25.3 240 (25.8) 13 (19.1) 2.46 (1.18–5.17)
> 200 23.0 203 (21.8) 27 (39.7) 1.0
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high during ageing and peaked at over 97 %. Within
men, seroprevalence increased from 84.6 % (<25 years)
to 96.4 % (35–45 years) with age. Around 6 % (15/250)
of women aged < 35 years, considered to be prime child
bearing age in Pakistan, remained IgG seronegative
when primary infection within men of corresponding
age was 219/252 (86.9 %). As such, 10 % of men under-
went viral seroconversion over a 20 year period, indicat-
ing a rate of primary infection of around 0.5 % per year
(Fig. 1). An individual’s level of education had a signifi-
cant effect on the odds of being IgG positive, with up to
6 years of education increasing the odds four times.
Lower levels of monthly income had greater odds of
being associated with higher IgG seroprevalence
compared to highest level of monthly income. Increased
crowding index was associated with greater odds of
having IgG positive test (Table 1).
The overall seroprevalence of IgM was 4.3 % (43/1000,
95 % CI: 3.2–5.7 %). Forty one individuals (41/1000,
4.1 %) were HCMV-IgM and HCMV-IgG seropositive,
whilst only 2 (2/1000, 0.2 %) were HCMV-IgM seroposi-
tive and HCMV-IgG seronegative. 95.3 % (41/43) of
individuals who were IgM seropositive were also
seropositive for IgG. Sixty six samples (6.6 %) were
found to be seronegative for HCMV. Smaller household
size for number of persons was strongly associated with
a higher seroprevalence of IgM (p = 0.008). Using
reference of HH size of > 10 persons, HH size of 1–3
persons had 23.3 % as IgM positive compared to 8.4 %
IgM negative (OR = 4.58 95 % CI: 1.47–14.72); HH size
of 4–6 persons had 25.6 % as IgM positive compared to
31.5 % IgM negative (OR = 1.35 95 % CI: 0.45–4.18); HH
size of 7–10 persons had 37.2 % IgM positive compared
to 36.9 % IgM negative (OR = 1.68 95 % CI: 0.61–4.89);
Fig. 1 Patterns of HCMV-IgG seroprevalence across different age groups in males (n = 462) and females (n = 535). The numbers below each bar
represent seropositive males and females in each corresponding age group
Table 1 Seroprevalence of anti-HCMV IgG antibodies in relation to sociodemographic characteristics of the study population
(Continued)
House construction materiala 0.79
Concrete bricks only 66.6 619 (66.5) 46 (67.6) 1.0
Mud and concrete mix 14.4 136 (14.6) 8 (11.8) 1.26 (0.56–2.97)
Straw/wood/mud 19.0 176 (18.9) 14 (20.6) 0.93 (0.48–1.83)
Crowding indexa 0.003
≤ 2 28.9 253 (27.4) 33 (48.5) 1.0
> 2–3 20.9 197 (21.4) 10 (14.7) 2.57 (1.18–5.72)
> 3–5 27.5 258 (28.0) 14 (20.6) 2.40 (1.21–4.84)
> 5 22.7 213 (23.1) 11 (16.2) 2.53 (1.19–5.45)
The adjusted OR and 95 % CI were calculated
USD U.S. dollar, OR odds ratio, CI confidence interval
*Comparisons between HCMV-IgG seroprevalence and sociodemographic characteristics were performed by Chi-square or Fisher’s exact test (p < 0.05)
aThe total sample size (n) for these variables may not equal the total number of samples (N = 1000) because information was unavailable
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with an overall adjusted OR of 2.1 (95 % CI: 1.2–4.2).
The seroprevalence of IgM did not differ significantly by
other variables.
In multivariable analysis adjusting for sampling location,
the odds of HCMV infection were nearly twice as high for
females compared to males (OR = 1.89 95 % CI: 1.10–3.25).
Increasing income on a log-transformed scale had lower
odds of being positive for HCMV infection (OR = 0.72
95 % CI: 0.54–0.96). Increasing age on a log-transformed
scale was associated with greater odds of seropositivity for
HCMV (OR= 3.95 95 % CI: 1.79–8.71) (Table 2). Univari-
ate analysis showed that “married” marital status was
significantly associated (p = 0.008) with HCMV-IgG sero-
prevalence, which was not observed when we undertook
multiple logistic regression analysis in the presence of
increasing age and other variables.
Discussion
In this study, we determined the seroprevalence of HCMV
infection in adult populations of Pakistan. Our results
reveal a high seroprevalence of HCMV infection, with an
average of 93.2 % of individuals aged ≥ 18 years, showing
the presence of HCMV-specific IgG antibodies indicative
of persistent infection. This is consistent with studies
reported from Asia, South America and the Caribbean
[10, 12, 24] but higher than that reported from North
America, Europe, Australia and Africa [7, 8, 15, 16, 25].
The IgM seroprevalence was 4.3 %, which is similar to
a previously reported estimate [26] but higher than
0.9–3 % IgM seroprevalence in several other countries
[11, 12, 27–30]. However, much greater variations in serum
IgM seroprevalence (0–19.5 %) have been reported from
developing countries [9, 31]. 95.3 % of individuals who were
IgM seropositive were also seropositive for IgG. In the
absence of either a confirmed sero-conversion or IgG
avidity testing it was not possible to define what proportion
of these cases represented primary infection or non-
primary reactivation of IgM. Interestingly, a recent analysis
of HCMV IgM seroprevalence in women of reproductive
age in USA also found that 97.5 % of IgM seropositive
women were CMV IgG seropositive [32]. IgG avidity testing
in countries with a high prevalence of HCMV infection,
such as Korea and Turkey; have shown that none of the
women with an IgM seropositive and IgG seropositive
sero-status had evidence of a primary infection [33, 34]. As
such, we would suggest that the great majority of IgM sero-
positive cases within our cohort represent viral recurrent
reinfection or reactivation rather than primary infection.
Despite the general very high seroprevalence of HCMV
infection, 6.6 % of the population remained seronegative.
It is likely that good hygiene, hand washing and limited
sharing of edibles and used utensils serve to limit infection
rates in some populations [35]. The low percentage of
individuals with a HCMV-IgM positive and HCMV-IgG
negative profile (0.2 %) indicates that the great majority of
infections occur during childhood although our data also
reveal a significant increase in seroprevalence of men
between the ages of 25 and 34 years.
Significant differences apparent in relation to the sero-
prevalence of HCMV infection in different locations are
likely to be attributed to the marked differences in
socioeconomic status between the government and
private hospital patient populations. In particular, a very
high proportion of the patients visiting JPMC belong to
the low socioeconomic strata of the society in whom
HCMV-IgG seroprevalence reached 95 %.
When we compared the HCMV-IgG seropositivity
between the different age groups, we observed a rise in
HCMV-IgG seropositivity from age group ≤ 25 years to
age group 35–45 years. However, this increase is not as
high as has been observed in previous studies and
reflects the high baseline prevalence of infection by the
time of early adulthood [16, 36]. Nevertheless, our
findings concur with other studies from areas of high
seroprevalence where a positive HCMV-IgG response
was observed in more than 90 % of the individuals in
the age group 18 to 35 years [9, 12].
Gender differences in HCMV seroprevalence have
been noted previously [7, 15, 16, 36]. In our study, youn-
ger adult males are shown to be much more vulnerable
to a primary HCMV infection than females and
seroprevalence within men increased by 12 % between
the age groups ≤ 25 years and 35–45 years. Women can
acquire primary infection through their own infected
children’s urine and saliva [37]. Therefore those women
who remain HCMV seronegative as they enter early
adulthood are more likely to be at risk of acquiring
HCMV infection from their children than men at this
stage. Importantly, nearly all women have had a primary
Table 2 Multiple logistic regression model for determinants of
HCMV-IgG seropositivity
Characteristic β value
(S.E.)
Adjusted OR
(95 % CI)
Gender
Female 0.63 (0.27) 1.89 (1.10–3.25)
Male (reference)
Household income in
USD (log-transformed)
−0.31 (0.14) 0.72 (0.54–0.96)
Age in years (log-transformed) 1.37 (0.40) 3.95 (1.79–8.71)
Sampling location
Private hospital (reference)
Government hospital 0.90 (0.37) 2.46 (1.18–5.13)
Community A −0.50 (0.65) 0.60 (0.16–2.19)
Community B 1.15 (0.51) 3.16 (1.14–8.71)
The adjusted OR and 95 % CI were calculated
USD U.S. dollar, S.E. standard error, OR odds ratio, CI confidence interval
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HCMV infection as they reach childbearing age in
contrast to developed countries where many women re-
main seronegative at reproductive age [15, 16, 25]. This
is important in relation to the potential susceptibility to
primary infection during pregnancy as this is associated
with risk of congenital transmission. The seroprevalence
of HCMV infection remained high in women of all ages
and was still found in 96 % of those aged over 45 years.
Interestingly, the seroprevalence of HCMV was slightly
reduced in men aged > 45 years. Reasons for this
age-related reduction are unclear. It is very unlikely that
seroprevalence of HCMV was lower during early adult-
hood in the current group of individuals aged > 45 years.
As such, it is possible that HCMV infection has been
associated with excess mortality within males, such that
the proportion of HCMV seronegative individuals may
have increased slightly over time. Indeed, infection has
regularly been correlated with a significant increase in
mortality rates in older individuals and it is possible that
this effect is more pronounced within male subjects in
developing countries.
Previous studies examining the relation between HCMV
seroprevalence and socioeconomic status in developing
countries have examined small sample size compared to
studies undertaken in developed countries [7, 18, 38]. By
targeting a relatively large population, we were able to
demonstrate an inverse relationship between socioeco-
nomic status and HCMV-IgG seroprevalence, which is
consistent with several previous reports [15, 17, 18, 36, 39].
However, in contrast to a previous study [7], household
size does not seem to contribute to the disparity in persist-
ent HCMV infection within our population. It has been
suggested that people at the lower ends of the education
and income spectrum are likely to spend longer time with
HCMV infection [17], primarily due to more crowded
living conditions [40]. However the definitive reason for
the increased seroprevalence of HCMV within poorer
communities remains unclear.
Univariate analysis showed a significant association
between ‘married’ marital status and HCMV IgG sero-
prevalence, which is reported to reflect increased viral
exposure via vertical and horizontal modes of transmis-
sion [37, 41]. The prevalence of HCMV infection did not
appear to be influenced by ethnicity in our population.
A unique feature of our study was an epidemiological
assessment of sociodemographic factors in relation to
IgM sero-status as this has not been widely studied
previously. An important finding was that only two
individuals were IgM seropositive but IgG seronegative,
a pattern which implies recent primary infection. How-
ever, false positive HCMV IgM results due to interfering
infections in IgG seronegative individuals may exist. As
such, as discussed above, IgM sero-status is likely to
reflect a humoral response to viral reinfection or
reactivation [28, 42]. Indeed, HCMV infection is unusual
in that IgM seropositivity can occur in individuals with
persistent infection, whereas an IgM antibody response
is generally observed only in the setting of acute infec-
tion for other pathogens. A striking observation was the
increased seroprevalence of HCMV-IgM in association
with decreasing household size. No association was seen
between IgM and increasing crowding index and so
increased frequency of HCMV transmission due to close
contact with infected individuals is unlikely to be an
explanation. Indeed our data may suggest an opposite
explanation, in that smaller families are less likely, at any
given time, to house an individual with primary infec-
tion. As such, it may be that the regular environmental
exposure to HCMV in larger families serves to boost
established HCMV-specific immunity and control en-
dogenous viral replication. In this regard, individuals
who do not get such regular environmental challenge
may undergo more frequent episodes of endogenous
viral replication, which would stimulate recurrent IgM
immune responses. Interestingly, a recent study of IgM
seroprevalence in US women observed a non-significant
increase in prevalence within single women compared to
married women (6.8 % vs 3.8 %) which could be compat-
ible with this observation [32]. Further epidemiological
and virological studies will be required to investigate this
observation further.
The two major strengths of this study included a large
sample size (N = 1000) and first estimate for HCMV
seroprevalence in diverse subgroups of population in a
developing country. Our comprehensive analysis was
based on a questionnaire which gathered data about
living conditions and provided an insight into the rea-
sons that could account for such a high seroprevalence
of this virus in a developing country.
Congenital infection with HCMV is a significant cause
of morbidity and mortality and several candidate HCMV
vaccines are under investigation. However, the develop-
ment of a vaccine programme must take into account
the potential risk of increasing the proportion of women
who remain HCMV seronegative as they enter preg-
nancy. Our findings reveal that up to 6 % of women of
childbearing age remain HCMV seronegative in Pakistan,
and the risk of primary infection within this group may
be significant given our observation that around 0.5 % of
men of a similar age may be undergoing primary infec-
tion each year, an event followed by prolonged viral
secretion, which could serve to drive infection in the
women who remain uninfected at this age.
Our study serves as a preliminary work towards im-
proved understanding about the status of HCMV infec-
tion in Pakistan; mainly so because such a large number
of participants with sociodemographic data has not been
studied for the assessment of this particular virus.
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Limitations
Some limitations of the work include the study design and
broad age categories, which prevented modeling of a
definitive temporal relationship between age and HCMV
seroprevalence.
Conclusions
In conclusion, this study suggests that the seroprevalence
of HCMV infection varies considerably by gender, age,
marital status and socioeconomic status in this setting in
Pakistan. Despite the high overall prevalence of HCMV
infection, around 6 % of women of childbearing age
remained at risk of primary infection. Amongst those with
persistent infection, people who live in smaller households
are more likely to demonstrate IgM seropositivity. IgM
production is likely to indicate a response to endogenous
viral reactivation and suggests that the more frequent
exposure to viral infection within larger household size
may boost protective endogenous immunity.
More research is needed to study and understand the
time trends in the epidemiology of HCMV infection
among seronegative pregnant women and neonates in
the high endemic population of Pakistan that would lead
to the initiation of a potential HCMV prevention and
vaccination programme when available.
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